Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9607 posts found.

Pharma and the iPhone: there’s an app for that

September 1, 2010 Medical Communications, Research and Development, Sales and Marketing ipad, iphone

The iPhone and its new, larger cousin the iPad, have captured the hearts of many technology lovers, and have ushered …
Feature

Talking R&D: Strategic vs full service CRO

September 1, 2010 Research and Development CRO, Talking Point, Talking R&D

CRF Health’s Greg Jewett and Medpace’s Alita Hassan debate the merits of a strategic or a full service contract research …
Feature
Roche building

Roche coy on job cut reports

September 1, 2010 Manufacturing and Production, Research and Development, Sales and Marketing Roche, job cuts

Roche is reportedly set to cut thousands of pharma jobs to reduce costs and boost profitability following a series of …
News

Kendle appoints Mark Roseman chief marketing officer

September 1, 2010 Research and Development Kendle, appointment, research and development

Mark Roseman has joined clinical research organisation Kendle as senior vice president and chief marketing officer. He has more than …
Appointment

Sanofi’s $18.5bn bid for Genzyme rejected

August 31, 2010 Manufacturing and Production, Research and Development, Sales and Marketing Genzyme, Sanofi-Aventis

Sanofi-Aventis has gone public with its $18.5 billion offer for Genzyme after the US biotech’s board unanimously rejected the bid …
News

Practical Approaches to Early Stage Life Sciences Technology Valuations – Part 2

August 26, 2010 Research and Development Kinapse, White paper, life sciences, pharma

With fierce competition in the market for late stage life sciences assets, pharmaceutical companies seeking partnering strategies to bolster pipelines …
Feature
White paper

Roche signs $1bn peptide deal with Aileron

August 25, 2010 Research and Development, Sales and Marketing Aileron, Roche, peptide, stapled peptide therapeutics

Roche has entered an agreement with a US biopharma company Aileron Therapeutics to develop and commercialise drugs called Stapled Peptide …
News

Sutent disappoints in lung cancer

August 24, 2010 Research and Development, Sales and Marketing NSCLC, Pfizer, Sutent, Tarceva

Pfizer’s Sutent has failed to improve overall survival in lung cancer patients when combined with Roche’s Tarceva. Pfizer’s SUN 1087 …
News

GSK shingles vaccine enters late stage trials

August 23, 2010 Research and Development, Sales and Marketing GSK, Vaccine, shingles

GlaxoSmithKline has started enrollment for phase III trials for its herpes zoster vaccine for the prevention of shingles. The trials …
News
Roche

Roche to acquire digital pathology specialists

August 23, 2010 Research and Development, Sales and Marketing Diagnostics, Roche

Roche has added to its portfolio of diagnostics products by acquiring US company BioImagene. The privately held Californian company specialises …
News
ASCO

ASCO 2010: The Hedgehog Pathway and other ways to target cancer

August 19, 2010 Research and Development ASCO, Cancer, thyroid cancer

The American Society of Clinical Oncology conference, one of the most important dates in the pharmaceutical industry’s calendar, took place …
Feature

Novartis and Quark sign gene silencing deal

August 19, 2010 Research and Development Novartis, Quark, SiRNA, rnai

Novartis has joined the race to develop a ‘gene silencing’ treatment by signing a new deal with siRNA specialist Quark …
News

Cell therapy industry partnership launched

August 18, 2010 Research and Development Genzyme, ISCT, Lonza, Roche

Pharma and biotech companies including Roche and Genzyme are to launch a series of initiatives to bolster progress in the …
News

Contract research news in brief

August 18, 2010 Research and Development Anavex, Cyprotex, Synexus

UK contract research organisation Synexus says it is reaping the benefits of its investments in Hungary in recent years, with …
News

Lilly abandons late stage Alzheimer’s drug

August 17, 2010 Research and Development Alzheimer's, lilly

Lilly is to abandon an Alzheimer’s drug in phase III development after results suggested it actually accelerated the disease rather …
News
The Gateway to Local Adoption Series

Latest content

Stage4You encourages stage 4 bowel cancer patients to prioritise mental health ahead of Bowel Cancer Awareness Month

March 26, 2026

Scotland starts newborn screening for SMA

March 26, 2026

Secarna appoints Jens Holstein and Richard Mark Engelhard to new Advisory Board

March 25, 2026

Roche adds 2,176 NVIDIA Blackwell GPUs to its hybrid-cloud AI factory

March 25, 2026

ReproNovo appoints Mark Altmeyer as Chairman of the Board

March 24, 2026